Logo image of DCGO

DOCGO INC (DCGO) Stock Fundamental Analysis

NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD

3.01  -0.08 (-2.59%)

Fundamental Rating

5

Taking everything into account, DCGO scores 5 out of 10 in our fundamental rating. DCGO was compared to 109 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, its profitability is only average at the moment. DCGO is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DCGO had positive earnings in the past year.
DCGO had a positive operating cash flow in the past year.
In multiple years DCGO reported negative net income over the last 5 years.
In the past 5 years DCGO reported 4 times negative operating cash flow.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.24%, DCGO belongs to the top of the industry, outperforming 86.92% of the companies in the same industry.
With a decent Return On Equity value of 9.48%, DCGO is doing good in the industry, outperforming 75.70% of the companies in the same industry.
The Return On Invested Capital of DCGO (8.61%) is better than 79.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DCGO is below the industry average of 8.18%.
The last Return On Invested Capital (8.61%) for DCGO is above the 3 year average (4.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.24%
ROE 9.48%
ROIC 8.61%
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 4.44%, DCGO is in the better half of the industry, outperforming 79.44% of the companies in the same industry.
Looking at the Operating Margin, with a value of 7.50%, DCGO is in the better half of the industry, outperforming 74.77% of the companies in the same industry.
Looking at the Gross Margin, with a value of 34.50%, DCGO is in the better half of the industry, outperforming 60.75% of the companies in the same industry.
In the last couple of years the Gross Margin of DCGO has declined.
Industry RankSector Rank
OM 7.5%
PM (TTM) 4.44%
GM 34.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DCGO is creating some value.
There is no outstanding debt for DCGO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 3.32 indicates that DCGO is not in any danger for bankruptcy at the moment.
DCGO's Altman-Z score of 3.32 is fine compared to the rest of the industry. DCGO outperforms 71.96% of its industry peers.
The Debt to FCF ratio of DCGO is 1.02, which is an excellent value as it means it would take DCGO, only 1.02 years of fcf income to pay off all of its debts.
DCGO has a better Debt to FCF ratio (1.02) than 88.78% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that DCGO is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.12, DCGO is doing good in the industry, outperforming 71.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.02
Altman-Z 3.32
ROIC/WACC1.03
WACC8.36%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.19 indicates that DCGO has no problem at all paying its short term obligations.
DCGO's Current ratio of 2.19 is fine compared to the rest of the industry. DCGO outperforms 75.70% of its industry peers.
A Quick Ratio of 2.19 indicates that DCGO has no problem at all paying its short term obligations.
The Quick ratio of DCGO (2.19) is better than 75.70% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.19
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

DCGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 285.71%, which is quite impressive.
EPS 1Y (TTM)285.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.36%

3.2 Future

Based on estimates for the next years, DCGO will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.92% on average per year.
Based on estimates for the next years, DCGO will show a very negative growth in Revenue. The Revenue will decrease by -14.69% on average per year.
EPS Next Y-59.52%
EPS Next 2Y-18.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-33.03%
Revenue Next 2Y-14.69%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

DCGO is valuated reasonably with a Price/Earnings ratio of 11.15.
Compared to the rest of the industry, the Price/Earnings ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 86.92% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of DCGO to the average of the S&P500 Index (29.98), we can say DCGO is valued rather cheaply.
A Price/Forward Earnings ratio of 27.54 indicates a quite expensive valuation of DCGO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCGO is on the same level as its industry peers.
DCGO's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.66.
Industry RankSector Rank
PE 11.15
Fwd PE 27.54
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

DCGO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DCGO is cheaper than 98.13% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 92.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.13
EV/EBITDA 3.46
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as DCGO's earnings are expected to decrease with -18.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.92%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DCGO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOCGO INC

NASDAQ:DCGO (3/3/2025, 2:05:04 PM)

3.01

-0.08 (-2.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)05-06 2025-05-06/amc
Inst Owners54.36%
Inst Owner Change3.26%
Ins Owners7.98%
Ins Owner Change7.61%
Market Cap307.17M
Analysts84.62
Price Target6.34 (110.63%)
Short Float %7.31%
Short Ratio11.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.79%
Min EPS beat(2)-8.5%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-4.64%
Min EPS beat(4)-31.37%
Max EPS beat(4)20.4%
EPS beat(8)3
Avg EPS beat(8)-47.91%
EPS beat(12)6
Avg EPS beat(12)72.25%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)-0.57%
Revenue beat(4)2
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)0.58%
Revenue beat(8)5
Avg Revenue beat(8)3.43%
Revenue beat(12)9
Avg Revenue beat(12)21.88%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 11.15
Fwd PE 27.54
P/S 0.44
P/FCF 7.13
P/OCF 5.96
P/B 0.94
P/tB 1.27
EV/EBITDA 3.46
EPS(TTM)0.27
EY8.97%
EPS(NY)0.11
Fwd EY3.63%
FCF(TTM)0.42
FCFY14.02%
OCF(TTM)0.5
OCFY16.78%
SpS6.81
BVpS3.19
TBVpS2.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.24%
ROE 9.48%
ROCE 15.18%
ROIC 8.61%
ROICexc 11.32%
ROICexgc 15.97%
OM 7.5%
PM (TTM) 4.44%
GM 34.5%
FCFM 6.2%
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
ROICexc(3y)11.17%
ROICexc(5y)N/A
ROICexgc(3y)17.48%
ROICexgc(5y)N/A
ROCE(3y)7.8%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 1.02
Debt/EBITDA 0.57
Cap/Depr 49.23%
Cap/Sales 1.22%
Interest Coverage 33.07
Cash Conversion 74.33%
Profit Quality 139.73%
Current Ratio 2.19
Quick Ratio 2.19
Altman-Z 3.32
F-Score7
WACC8.36%
ROIC/WACC1.03
Cap/Depr(3y)69.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)285.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-59.52%
EPS Next 2Y-18.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-39.36%
Revenue Next Year-33.03%
Revenue Next 2Y-14.69%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y243.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year296.97%
EBIT Next 3Y35.17%
EBIT Next 5YN/A
FCF growth 1Y66.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.1%
OCF growth 3YN/A
OCF growth 5YN/A